A first-in-human study of the safety of an immunosuppressive antibody (IMP761) in healthy volunteers.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-510761-42-00

Acronym

IMP761-P001

Enrollment

Registered

2024-07-16

Start date

2024-07-17

Completion date

Unknown

Last updated

2025-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmunity

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026